#ICYMI : There's still time to register for our upcoming #CDERSBIA virtual webinar, Statistical Considerations for Premarketing Risk Assessment, on May 16 from 1 PM - 2:30 PM ET.

Learn more and register today: fda.gov/drugs/news-eve…

Don’t miss it! There's still time to register for our upcoming #CDERSBIA virtual webinar, Redesigned Pre-Submission Meetings in GDUFA III: Benefits for ANDA Submission and Approval, on May 9 from 1 PM - 3 PM ET.

Learn more and register today: fda.gov/drugs/news-eve…

Don't miss keynote speaker, FDA Commissioner Dr. Robert M. Califf at next week’s #CDERSBIA REdI Conference!

Learn from FDA’s regulatory experts and gain product development insights on drugs, devices, & biologics.

Register: fda.gov/drugs/news-eve…

📢 #ICYMI : There's still time to register for our upcoming #CDERSBIA virtual webinar, Facilitating Generic Drug Product Development through Product-Specific Guidances, on April 25 from 1 PM - 4:00 PM ET.

Learn more and register today: fda.gov/drugs/news-eve…

Join FDA Center Directors from CDER, CBER, & CDRH for a closer look at how FDA advances programs through user fees support during the plenary session of #CDERSBIA ’s Regulatory Education for Industry Conference June 5–9.

Register: fda.gov/drugs/news-eve…

Join FDA Drug Information, FDA Biologics, and FDA Medical Devices center directors for a closer look at how we advance programs through user fees support during the plenary session of #CDERSBIA 's Regulatory Education for Industry Conference June 5 -9.

Register ➡️bit.ly/3Ot1naf

As a goal, #CDERSBIA aims to help small pharmaceutical business and industry navigate the wealth of information that #FDA offers, and to assist in understanding human drug product regulation. Join this upcoming webinar on September 6th, 2023 fda.gov/drugs/news-eve…

As a goal, #CDERSBIA aims to help small pharmaceutical business and industry navigate the wealth of information that #FDA offers, and to assist in understanding human drug product regulation.
Join this upcoming webinar on September 6th, 2023 fda.gov/drugs/news-eve…

As a goal, #CDERSBIA aims to help small pharmaceutical business and industry navigate the wealth of information that #FDA offers, and to assist in understanding human drug product regulation. Join this upcoming webinar on September 6th, 2023 fda.gov/drugs/news-eve…

As a goal, #CDERSBIA aims to help small pharmaceutical business and industry navigate the wealth of information that #FDA offers, and to assist in understanding human drug product regulation. Join this upcoming webinar on September 6th, 2023 fda.gov/drugs/news-eve…

Thank you to everyone who participated in the #CDERSBIA REdI Conference last week. The conference has been recorded on YouTube Live and is now available to view. #MedicalDevice #FDA sbiaevents.com/redi2023/

Thank you to everyone participating in #CDERSBIA REdI Conference this week. It was a pleasure to speak about how CDER’s user fee support from PDUFA, BsUFA, & GDUFA programs advance FDA’s role as global leaders in drug innovation, access, & affordability: fda.gov/drugs/news-eve…

Please join Commissioner Dr. Robert M. Califf, FDA Biologics Director Peter Marks, FDA/CDRH Industry Director Jeff Shuren and me this morning as we kick off the 2023 #CDERSBIA REdI Conference: fda.gov/drugs/news-eve…